These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20603149)

  • 21. Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease.
    Bodolay E; Aleksza M; Antal-Szalmás P; Végh J; Szodoray P; Soltész P; Szegedi A; Szekanecz Z
    J Rheumatol; 2002 Oct; 29(10):2136-42. PubMed ID: 12375323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein kinase C-dependent activation of CaV1.2 channels selectively controls human TH2-lymphocyte functions.
    Robert V; Triffaux E; Paulet PE; Guéry JC; Pelletier L; Savignac M
    J Allergy Clin Immunol; 2014 Apr; 133(4):1175-83. PubMed ID: 24365142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and biochemical characterization of a novel nortriterpene inhibitor of the human lymphocyte voltage-gated potassium channel, Kv1.3.
    Felix JP; Bugianesi RM; Schmalhofer WA; Borris R; Goetz MA; Hensens OD; Bao JM; Kayser F; Parsons WH; Rupprecht K; Garcia ML; Kaczorowski GJ; Slaughter RS
    Biochemistry; 1999 Apr; 38(16):4922-30. PubMed ID: 10213593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockage of K(Ca)3.1 and Kv1.3 channels of the B lymphocyte decreases the inflammatory monocyte chemotaxis.
    Zhang S; Wang X; Ju C; Zhu L; Du Y; Gao C
    Int Immunopharmacol; 2016 Feb; 31():266-71. PubMed ID: 26795234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological inhibition of Kv1.3 fails to modulate insulin sensitivity in diabetic mice or human insulin-sensitive tissues.
    Straub SV; Perez SM; Tan B; Coughlan KA; Trebino CE; Cosgrove P; Buxton JM; Kreeger JM; Jackson VM
    Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E380-90. PubMed ID: 21586699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered activation of peripheral CD8+ T cells in pediatric Crohn's disease.
    Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
    Immunol Lett; 2017 May; 185():48-51. PubMed ID: 28300604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitors of potassium channels KV1.3 and IK-1 as immunosuppressants.
    Pegoraro S; Lang M; Dreker T; Kraus J; Hamm S; Meere C; Feurle J; Tasler S; Prütting S; Kuras Z; Visan V; Grissmer S
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2299-304. PubMed ID: 19282171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.
    Koshy S; Huq R; Tanner MR; Atik MA; Porter PC; Khan FS; Pennington MW; Hanania NA; Corry DB; Beeton C
    J Biol Chem; 2014 May; 289(18):12623-32. PubMed ID: 24644290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential susceptibility to activation-induced apoptosis among peripheral Th1 subsets: correlation with Bcl-2 expression and consequences for AIDS pathogenesis.
    Ledru E; Lecoeur H; Garcia S; Debord T; Gougeon ML
    J Immunol; 1998 Apr; 160(7):3194-206. PubMed ID: 9531275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of T-cell reactivity with beta-cell function in recent onset type 1 diabetes patients.
    Pfleger C; Meierhoff G; Kolb H; Schloot NC;
    J Autoimmun; 2010 Mar; 34(2):127-35. PubMed ID: 19744828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of T cell potassium channels, KV1.3 and KCa3.1, in the inflammatory cascade in ulcerative colitis.
    Hansen LK
    Dan Med J; 2014 Nov; 61(11):B4946. PubMed ID: 25370966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential calcium signaling and Kv1.3 trafficking to the immunological synapse in systemic lupus erythematosus.
    Nicolaou SA; Neumeier L; Takimoto K; Lee SM; Duncan HJ; Kant SK; Mongey AB; Filipovich AH; Conforti L
    Cell Calcium; 2010 Jan; 47(1):19-28. PubMed ID: 19959227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor.
    Jun HX; Jun CY; Yu ZX
    Haematologica; 2004 Dec; 89(12):1517-24. PubMed ID: 15590404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive evidence of Tityus serrulatus toxins Ts6 and Ts15: insights of a novel K(+) channel pattern in T cells.
    Pucca MB; Bertolini TB; Cerni FA; Bordon KC; Peigneur S; Tytgat J; Bonato VL; Arantes EC
    Immunology; 2016 Feb; 147(2):240-50. PubMed ID: 26595158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo.
    Koo GC; Blake JT; Talento A; Nguyen M; Lin S; Sirotina A; Shah K; Mulvany K; Hora D; Cunningham P; Wunderler DL; McManus OB; Slaughter R; Bugianesi R; Felix J; Garcia M; Williamson J; Kaczorowski G; Sigal NH; Springer MS; Feeney W
    J Immunol; 1997 Jun; 158(11):5120-8. PubMed ID: 9164927
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different TH2-TH1 balance in V beta 8 and V beta 6 subsets of splenocytes in NOD females in the early phase of diabetogenesis.
    Atlan-Gepner C; Hermitte L; Janand-Delenne B; Naquet P; Vialettes B
    Diabetes Metab; 1997 Nov; 23(5):386-94. PubMed ID: 9416430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kv1.3/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages.
    Villalonga N; Escalada A; Vicente R; Sánchez-Tilló E; Celada A; Solsona C; Felipe A
    Biochem Biophys Res Commun; 2007 Jan; 352(4):913-8. PubMed ID: 17157812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Th1 and Th2 cell responses of type 1 diabetes patients and healthy controls to human heat-shock protein 60 peptides AA437-460 and AA394-408.
    Szebeni A; Schloot N; Kecskeméti V; Hosszúfalusi N; Pánczél P; Prohászka Z; Füst G; Uray K; Hudecz F; Meierhoff G
    Inflamm Res; 2005 Oct; 54(10):415-9. PubMed ID: 16283109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans.
    Rep MH; van Oosten BW; Roos MT; Adèr HJ; Polman CH; van Lier RA
    J Clin Invest; 1997 May; 99(9):2225-31. PubMed ID: 9151795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered calcium influx of peripheral Th2 cells in pediatric Crohn's disease: infliximab may normalize activation patterns.
    Orbán C; Szabó D; Bajnok A; Vásárhelyi B; Tulassay T; Arató A; Veres G; Toldi G
    Oncotarget; 2016 Jul; 7(29):44966-44974. PubMed ID: 27329601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.